← Eichor
Condition: Aggression Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Aggression

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Phase 2 · 2 location(s) · Jeremy Veenstra-vanderweele · NCT07091279Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
NA · 1 location(s) · Rhode Island Hospital · NCT06769282Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma
Phase 2 · 1 location(s) · Koo Foundation Sun Yat-Sen Cancer Center · NCT06461182Extensions of Resurgence as Choice
NA · 1 location(s) · Rutgers, The State University of New Jersey · NCT05537610Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
Phase 2/Phase 3 · 1 location(s) · Children's Cancer Group, China · NCT07168980Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed
Phase 2 · 6 location(s) · Academic and Community Cancer Research United · NCT06238648A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic
Phase 1 · 8 location(s) · Autolus Limited · NCT06173518The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Phase 1/Phase 2 · 11 location(s) · AVM Biotechnology Inc · NCT04329728Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Maligna
Phase 1/Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT05674825Alcohol & Men's Sexual Risk Behaviors
NA · 1 location(s) · Arizona State University · NCT06158880Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06244368Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06609330Manualized Assessment and Treatment Model of Challenging Behavior
NA · 1 location(s) · Rutgers, The State University of New Jersey · NCT05928247Virtual Reality Aggression Prevention Training (VRAPT) for (Forensic) Psychiatric Patients
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT05293834Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Phase 1/Phase 2 · 1 location(s) · Hiroshima University Hospital · NCT05863234Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03048266Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Canc
Phase N/A · 26 location(s) · AstraZeneca · NCT07052578A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
Phase 4 · 1 location(s) · Milton S. Hershey Medical Center · NCT06871488Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) a
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT07179783Wise Intervention for Reducing Aggressive Behaviors and Promoting Prosocial Behaviors Toward LGB-TNB Individuals
NA · 1 location(s) · University of Deusto · NCT07212283Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06738303A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Phase 3 · 87 location(s) · UCB Biopharma SRL · NCT07219420Aggressive Smoking Cessation Trial (ASAP)
Phase 3 · 13 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT05257629Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
Phase 2 · 1 location(s) · Fundacion Oncosur · NCT05563558Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Phase 2 · 1 location(s) · Eastern Virginia Medical School · NCT04436081Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to C
Phase 3 · 174 location(s) · SWOG Cancer Research Network · NCT06470243A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Phase 1/Phase 2 · 37 location(s) · Dren Bio · NCT05475925
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.